Decreasing the Unplanned Readmission Rate of Patients receiving Outpatient Antibiotic Therapy(OPAT)

Similar documents
Influence of Patient Flow on Quality Care

Decreasing Readmissions in Outpatient Parenteral AntImicrobial Therapy (DROP IT)

Influence of Patient Flow on Quality Care

C. difficile Infection and C. difficile Lab ID Reporting in NHSN

Strategies to Reduce Readmissions, Sepsis, and Health-Care Associated Infections

Leveraging the Accountable Care Unit Model to create a culture of Shared Accountability

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI

Failure to Maintain: Missed Care and Hospital-Acquired Pneumonia

Administrative Update: How to Implement Discharge Pharmacy Services (DPS) Objectives

Kentucky Sepsis Summit. August 2016

Pharmaceutical Services Report to Joint Conference Committee September 2010

Discharge and Follow-Up Planning. Presented by the Clinical and Quality Team

PRISM Collaborative: Transforming the Future of Pharmacy PeRformance Improvement for Safe Medication Management

Improving the Chemotherapy Appointment Experience at the BC Cancer Agency

Medication Errors and Safety. Educating for Quality Improvement & Patient Safety

Decreasing Lag Time for Ward Collect Lab Draws

Clinical Safety & Effectiveness Cohort # 11

PSYCHIATRY SERVICES UPDATE

Aldijana Avdić, BSN, RN, PBMS, CPHQ Assistant Director, Patient Safety and Privacy 1

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit

Tina Nelson, MBA, BSN Lisa Stepp, BSN, RN Rebecca Fyffe, BSN, RN Jessica Coughenour, LPN

Blood Culture Contamination

Executive Summary MEDICARE FEE-FOR-SERVICE (FFS) HOSPITAL READMISSIONS: QUARTER 4 (Q4) 2012 Q STATE OF CALIFORNIA

1. March RN VACANCY RATE: Overall 2320 RN vacancy rate for areas reported is 13.8%

Corporate Services Employment Report: January Employment by Staff Group. Jan 2018 (Jan 2017 figure: 1,462) Overall 1,

Improve the Efficiency and Service of the Emergency Room at North Side Hospital

Quality Management Report 2017 Q2

Compliance Division Staff Report

Outpatient parenteral antimicrobial therapy

EMR Adoption: Benefits Realization

Beth Ann Ayala, Jim Lewis, and Tom Patterson DATE. Educating for Quality Improvement & Patient Safety

Heart Failure Order Sets. Standardizing Care for the Heart Failure Patient 2012

PPI Deprescribing: Ascension

IMPROVING TRANSITIONS FROM ACUTE CARE TO REHAB: SPREADING CHANGE ACROSS GTA HOSPITAL SITES FOR PATIENTS POST-HIP FRACTURE

Please place your phone line on mute.

Innovation in Self-Care

Decreasing Nosocomial C. diff

Baptist Health System Jacksonville, FL

Hospitalization Patterns for All Causes, CV Disease and Infections under the Old and New Bundled Payment System

Hip Today Home Tomorrow:

1. November RN VACANCY RATE: Overall 2320 RN vacancy rate for areas reported is 12.5%

On behalf of COMMIT Team

QIO Care Transitions Activity: the Good News so far

Transitioning OPAT (Outpatient Antibiotic Therapy) patients from the Acute Care Setting to the Ambulatory Setting

Driving High-Value Care via Clinical Pathways. Andrew Buchert, MD Gabriella Butler, MSN, RN

Transitions of Care Project BOOST

National Trends Winter 2016

Key Steps in Creating & Sustaining Excellence

UHF Quality Institute. Patient-Reported Outcomes in Primary Care New York PROPC-NY. Module 2 Webinar

HOW TO DO POST-HOC RESPONSE REVIEWS

Enlisted Professional Military Education FY 18 Academic Calendar. Table of Contents COLLEGE OF DISTANCE EDUCATION AND TRAINING (CDET):

National Readmissions Summit Safe and Reliable Transitions: An Integrated Approach Reducing Heart Failure Readmissions

L19: Improving Transitions from the Hospital to Post Acute Care Settings

Readmission Reduction: Patient Interviews. KHA Quality Conference March, 2018

Relational Coordination: An Imperative Influencing our Capacity to Reach the Core

BOROUGH OF ROSELLE PUBLIC NOTICE ANNUAL NOTICE OF CALENDAR YEAR 2018 WORKSHOP SESSIONS, PRE-AGENDA MEETINGS AND REGULAR MEETINGS

Activity Based Cost Accounting and Payment Bundling

Improvements & Sustained Change through the Implementation of High Reliability Units

IMPLEMENTING A NURSE-LED COMMUNITY INTRAVENOUS ANTIBIOTIC SERVICE

Behavioral Health Division JPS Health Network

CAUTI Reduction A Clinton Memorial Presentation

Change Management at Orbost Regional Health

Julie Kelley, MSW, MPH Program Chief, Mental Heath/Psychiatry Contra Costa Regional Medical Center Martinez, CA

CV SURGERY 30 DAY RE-ADMISSION. CMS IS WATCHING YOU, AND YOU, AND ME TOO.

Readmission Project 2017 Janice M. Maupin, RN, MSN, CPHQ. A Catholic healthcare ministry serving Ohio and Kentucky

Ambulatory OPAT in paediatrics: same but different?

9/15/2017 THROUGHPUT. IT S NOT JUST AN EMERGENCY DEPARTMENT ISSUE LEARNING OBJECTIVES

PATIENT CARE SERVICES REPORT Submitted to the Joint Conference Committee, August 2016

Transitions of Care Innovations in the Medical Practice Setting

Stakeholder input is gathered in several ways. Patients are given the opportunity to provide feedback, the SWOT analysis is based on information from

Ontario Shores Journey to EMRAM Stage 7. October 21, 2015

SPSP Medicines. Prepared by: NHS Ayrshire and Arran

HIMSS Nicholas E. Davies Award of Excellence Case Study Nebraska Medicine October 10, 2017

PATIENT CARE SERVICES REPORT Submitted to the Joint Conference Committee, November 2017

Translating Evidence to Safer Care

Patient Safety in Ambulatory Care: Why Reporting Counts. August 11, 2010 Diane Schultz, RPh and Sheila Yates, MPH

After reading this learning module, the nurse should be able to:

Northern Health - Acute Services. Evidence Based Practice Venous Thromboembolism Prevention

Integrating Quality Into Your CDI Program: The Case for All-Payer Review

Presentation Outline

Safety in Mental Health Collaborative

JANUARY 2018 (21 work days) FEBRUARY 2018 (19 work days)

UNIVERSITY OF ILLINOIS HOSPITAL & HEALTH SCIENCES SYSTEM HOSPITAL DASHBOARD

CHC-A Continuity Dashboard. All Sites Continuity - Asthma. 2nd Qtr-03. 2nd Qtr-04. 2nd Qtr-06. 4th Qtr-03. 4th Qtr-06. 3rd Qtr-04.

Establishing a Culture of Quality and Safety and the Journey to High Reliability

CHF Readmission Initiative. Mary Fischer MSN, CCRN, PCCN, CHFN Cardiology Clinical Nurse Specialist St. Vincent Hospital Indianapolis, Indiana

Use of TeleMedicine to Improve Clinical and Financial Outcomes

LESSONS LEARNED IN LENGTH OF STAY (LOS)

Combining Nursing Power and Quality Metrics to Influence Policy Development

PERFORMANCE IMPROVEMENT REPORT

Alaska Psychiatric Institute. Admissions & Demographic Annual Report

Catalog. Community and Societal Pediatrics - Jacksonville. Prerequisites. Course Description. Course Faculty and Staff

PACE Performance on Post-Discharge Primary Care Evaluations from Jan-Jun 2012 PACE. By: Rocio Solano Padilla PCLP-NMF/GE Scholar Jul 23, 2012

PERFORMANCE MANAGEMENT MEETING. Health Department:

Worth a Thousand Words: Telling a Story with Data

Adapting to changing times.. The challenge & the power of person-centredness

Update to OPAT Good Practice Recommendations

Catherine Porto, MPA, RHIA, CHP Executive Director HIM. Madelyn Horn Noble 3M HIM Data Analyst

of the respiratory checklist from July1, April 30, Measures were evaluated monthly. Primary measures:

2016/17 Activity Report April August/September 2016

Transcription:

Decreasing the Unplanned Readmission Rate of Patients receiving Outpatient Antibiotic Therapy(OPAT) Dr. Jose Cadena Dr. Amruta Parekh University of Texas Health Science Center at San Antonio San Antonio, TX

CONTACT Jose Cadena, M.D. (210) 567-1871 cadenazuluag@uthscsa.edu

TEAM PHYSICIANS Chief / Medical Service Jan Patterson, MD Infectious Disease Fellow Jose Cadena, MD FACILITATOR Amruta Parekh, MD, MPH NURSING Irene Cataldo, R.N. Theresa Gore, RN. PHARMACY Kelly Echeverria PharmD TECH/STATISTICAL SUPPORT Wayne Fischer, MS, PhD

LIST OF CUSTOMERS PATIENTS PROVIDERS NURSING PHARMACY HOSPITAL ADMINISTRATION

AIM STATEMENT To decrease the unplanned readmission rate of patients receiving outpatient antibiotic therapy (OPAT) due to infection, line complications or adverse drug reactions by 30% by December 2008 at ALMVA hospital.

What was the VA working with? We retrospectively evaluated the failures among patients receiving OPAT at the ALMVA over a 3 month period. Rate of Adequate Follow up 32% Rate of readmission 44% (54% of which within 2 weeks) Rate of Central Line Complication 12% Rate of Antibiotic Complications(rash, C 36% difficile associated disease-cdad, failure) Patients alive at end of therapy 84% Patients with microbiological diagnosis 68%

PROCESS FLOW - Pre Intervention

CAUSE & EFFECT DIAGRAM Coordination of efforts

BACKGROUND Outpatient Antibiotic Therapy (OPAT) is an alternative to inpatient care. It is safe and effective when used properly. Proper assessment of the patients required: OPAT indication, social situation and comorbidities Ordering physician: Should be aware of the team work, communication, monitoring and outcome measurements! Patient should be informed of his responsibilities and plan to follow up. Antibiotics: Proper choice, dosing and monitoring. Initiated in hospital or clinic. Tice et al. Clin Infect Dis 2004;38: 1651 72

PERTINENT POINTS FROM LITERATURE OPAT is a complex process. A Healthcare Failure Mode Effect Analysis has shown that OPAT may have 6 processes, 67 sub-processes and 217 possible failures. Our project was a first step to standardize and improve the process. Gilchrist M et al. J Antimicrob Chemotherapy 2008; 62: 177 83.

Mandatory ID consultation for OPAT Infectious diseases consultation results in change in management of 88.6% patients considered candidates for OPAT Mandatory ID consultation decreases cost by $760 per patient. High success rate of therapy (97%) Sharma R, Loomis W, Brown R. Am J Med Sci 2005;330:60 64.

But remember.. OPAT may have 6 processes, 67 subprocesses and 217 possible failures. Gilchrist M et al. J Antimicrob Chemotherapy 2008; 62: 177 83.

How Infectious Disease Physician and ID PharmD: Review cases to make sure that therapy is appropriate Ensure ID clinic follow up when appropriate Address complications in the clinic Review the patient to make sure they are able to care for themselves. Discuss with team and patient goals and responsibilities of therapy. Constant communication between MD, Pharm D, RN and home health.

% readmitted on Tx Preintervention data of readmissions during treatment 102.8 82.8 UCL 81.8 62.8 42.8 CL 30.8 22.8 2.8-17.2 LCL -20.2-37.2 January February March April May June July Months

PROCESS FLOW - Post Intervention Intervention Decision diamonds

% readmitted on Tx 102.8 82.8 Postintervention data of readmissions during treatment Preintervention UCL 81.8 Postintervention 62.8 49.9 42.8 CL 30.8 22.8 16.7 2.8-17.2 LCL -20.2-16.6-37.2 January February March April May June July August September October November December

Readmits / 1000 Pt-Days of Treatment 180.0 160.0 Pre intervention: 28.9 per 1000 OPAT days Readmissions within 30 Days Readmissions at 3 months Post intervention: 12.1 per 1000 OPAT days 140.0 120.0 100.0 80.0 UCL=86.5409 60.0 40.0 20.0 CL=16.7683 0.0 LCL=0.0000 Jan 2008 Feb 2008 Mar 2008 Apr 2008 May 2008 Jun 2008 Jul 2008 Aug 2008 Sep 2008 Oct 2008 Nov 2008Dec 2008 Month Pre intervention OPAT days 693 Post intervention OPAT days 663

Rate of completion of parental therapy Preintervention Postintervention Total Number 47 37 Completed Treatment 26 (55%) 30 (81%) Did not complete 21 (45%) 7 (19%) p=0.04 Postintervention rate of completion of parental therapy was better

Complications Requiring Readmissions Pre intervention N: 47 Post intervention N: 37 CHF/Volume overload 3 0 ARF, electrolyte disturbance 3 0 PICC line Infection/removal 4 (2/2) 0 Amputations 4 1 Worsening Infection 8 1 SJS/Severe rash/toxicity 2 1 All-Cause Mortality 2 2 Total 17 (36%) 4 (13%) Number of patients with serious complications requiring readmission reduced in the post intervention period

Complications (overall) N:47 N:37 Acute Renal Failure 3 (6%) 2 (5%) Congestive Heart Failure 3 (6%) 0 PICC problems 4 (9%) 2 (5%) Amputations 4 (9%) 1 (3%) Unrelated readmissions 6 (12%) 5 (14%) Worsening Infection 8 (17%) 1 (3%) SJS/Severe rash/toxicity 2 (4%) 1 (3%) All-Cause Mortality 2 (4%) 2 (5%) Total 32 14

Follow up and readmissions Follow up at 7 days (labs)* Follow up within 2 weeks (MD) * Pre intervention Post intervention P value 21/39 (54%) 21/36 (62%) 0.7 22/36 (61%) 26/35 (74%) 0.2 Readmitted during treatment Readmitted within 3 months 15/47 (32%) 5/37 (14%) 0.049 20/47 (43%) 8/37 (22%) 0.043 *Denominator: eligible patients.

RETURN ON INVESTMENT % Patients Readmitted Admissions / Month* Average LOS Pre intervention 43% 3.2 14 days Post intervention 22% 1.7 Cost - Physician FTE (2/8) ($43,849) Potential Admissions Avoided / Yr 18 Potential Admission Days Avoided / Yr** 252 Cost Savings (if only regular bed days avoided would $428,400 be higher for higher level of care) Cost savings cost physician $384,551 Return on investment 89% *Assume 90 patients per year ** Hospital day cost 1700$

Number on Tx WHERE ARE WE GOING? Program was transiently discontinued pending resolution of funding issues. There was a proposal to create a position for an ID physician to supervise the process and was submitted to the hospital directives April 2009: Approved position. Recruitment completed. Plan to restart program in July 2009. 18 16 14 12 10 8 6 4 2 0 UCL 14.49 CL 6.71 15.56 7.40 Date/Time/Period

CONCLUSIONS ID physician direction Decreased complications and readmission Cost-effective and cost-saving Improved quality and patient safety Most complications could be managed as outpatient Process was initially labor intensive but rewarding Further improvement is required for patients with less prolonged hospital stay.

QUESTIONS?